Titan Pharmaceuticals, Inc.

South San Francisco, CA 94080

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.65MM
First Award Date 09/20/99
Most Recent Award Date 08/01/11

Key Personnel

Last Name Name Awards Contact
Allen Richard C Allen 3
Patel Rajesh Patel 2
Sreedharan Sunil P Sreedharan 2

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/01/11 - 01/31/13

DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a progressive neurodegenerative disorder associated with a loss of dopaminergic nigrostriatal neurons. There are over 1.5 million PD patients in the US, with about 50,000 new patients each year. The cornerstone of symptomatic treatment for PD is dopamine replacement therapy, and do...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a progressive neurodegenerative disorder associated with a loss of dopaminergic nigrostriatal neurons. There are over 1.5 million PD patients in the US, with about 50,000 new patients each year. The cornerstone of symptomatic treatment for PD is dopamine replacement therapy, and do...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02

Parkinson's disease (PD) is a disease of the central nervous system characterized by the reduction of dopamine (DA)-producing nerve cells in the substantia nigra, which results in chronic and progressive motor impairment. As late stage PD patients become intolerant of or resistant to the standard pharmacological therapies, surgical grafting of f...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/00 - 08/31/01

Parkinson's disease (PD) is a disease of the central nervous system characterized by the reduction of dopamine (DA)-producing nerve cells in the substantia nigra, which results in chronic and progressive motor impairment. As late stage PD patients become intolerant of or resistant to the standard pharmacological therapies, surgical grafting of f...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/20/99 - 09/29/00

Parkinson's disease (PD) is a disease of the central nervous system characterized by the reduction of dopamine (DA)-producing nerve cells in the substantia nigra, which results in chronic and progressive motor impairment. As late stage PD patients become intolerant of or resistant to the standard pharmacological therapies, surgical grafting of f...